Pharmacogenetic targeting of drugs for heart failure-Reference-Cited by-同舟云学术

Pharmacogenetic targeting of drugs for heart failure

Published:2012-04 Issue:1 Volume:134 Page:107-115
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Bristow Michael R.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference55 articles.

1. Prevention of atrial fibrillation by bucindolol is completely dependent on the Beta-1 389 Arg/Gly adrenergic receptor polymorphism;Aleong;Circulation,2011

2. Pharmacogenomics of 4-hydroxycoumarin anticoagulants;Au;Drug Metab Rev,2008

3. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes;Beshai;N Engl J Med,2007

4. Constitutive nitric oxide synthase activation is a significant route for nitroglycerin-mediated vasodilation;Bonini;Proc Natl Acad Sci,2008

5. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension;Bonnardeaux;Hypertension,1994

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions Networks for Primary Heart Sarcomas;Cancers;2021-08-01

2. Synthesis, Characterization, In Silico Analysis, and Pharmacological Evaluation of Metoprolol-Modified Saccharide Conjugates for Cardiovascular Targeting;Journal of Pharmaceutical Innovation;2021-07-28

3. In silico design and pharmacological evaluation of conjugates of atenolol with modified saccharide for cardiovascular targeting;Glycoconjugate Journal;2021-03-09

4. Treatment of HF in an Era of Multiple Therapies;JACC: Heart Failure;2021-01

5. Drug Repositioning: Principles, Resources, and Application of Structure-Based Virtual Screening for the Identification of Anticancer Agents;Molecular Docking for Computer-Aided Drug Design;2021